Richard Katz MD brings proven expertise to pharmaceutical regulatory consulting, specializing in registrational clinical trials and global drug approval strategies. With comprehensive healthcare administration experience, Dr. Katz guides biopharmaceutical organizations from Phase II optimization through successful market authorization.